1. Home
  2. IMRN vs ATER Comparison

IMRN vs ATER Comparison

Compare IMRN & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • ATER
  • Stock Information
  • Founded
  • IMRN 1994
  • ATER 2014
  • Country
  • IMRN Australia
  • ATER United States
  • Employees
  • IMRN N/A
  • ATER N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • ATER Home Furnishings
  • Sector
  • IMRN Health Care
  • ATER Consumer Discretionary
  • Exchange
  • IMRN Nasdaq
  • ATER Nasdaq
  • Market Cap
  • IMRN 9.2M
  • ATER 10.4M
  • IPO Year
  • IMRN N/A
  • ATER N/A
  • Fundamental
  • Price
  • IMRN $1.86
  • ATER $0.98
  • Analyst Decision
  • IMRN Strong Buy
  • ATER
  • Analyst Count
  • IMRN 1
  • ATER 0
  • Target Price
  • IMRN $5.00
  • ATER N/A
  • AVG Volume (30 Days)
  • IMRN 55.1K
  • ATER 121.7K
  • Earning Date
  • IMRN 08-29-2025
  • ATER 08-13-2025
  • Dividend Yield
  • IMRN N/A
  • ATER N/A
  • EPS Growth
  • IMRN N/A
  • ATER N/A
  • EPS
  • IMRN N/A
  • ATER N/A
  • Revenue
  • IMRN $4,777,422.00
  • ATER $85,668,000.00
  • Revenue This Year
  • IMRN N/A
  • ATER N/A
  • Revenue Next Year
  • IMRN N/A
  • ATER $7.48
  • P/E Ratio
  • IMRN N/A
  • ATER N/A
  • Revenue Growth
  • IMRN 48.63
  • ATER N/A
  • 52 Week Low
  • IMRN $1.50
  • ATER $0.90
  • 52 Week High
  • IMRN $2.87
  • ATER $3.84
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 56.87
  • ATER 36.18
  • Support Level
  • IMRN $1.73
  • ATER $0.94
  • Resistance Level
  • IMRN $1.89
  • ATER $1.07
  • Average True Range (ATR)
  • IMRN 0.10
  • ATER 0.05
  • MACD
  • IMRN 0.01
  • ATER 0.01
  • Stochastic Oscillator
  • IMRN 76.77
  • ATER 33.41

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About ATER Aterian Inc.

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.

Share on Social Networks: